M. Dalinghaus

M. Dalinghaus is a Researcher in the Department of Pediatrics at Erasmus MC, specializing in pediatric cardiology with extensive research output including 71 publications and supervision of 4 students. The research profile demonstrates significant expertise in dilated cardiomyopathy, heart failure mechanisms, and pediatric heart transplantation.

• Pediatrics Medicine and Dentistry 100%
• Dilated Cardiomyopathy Medicine and Dentistry 56%
• Congestive Heart Failure Pharmacology 50%
• Tubulin Biochemistry and Molecular Biology 47%
• Heart Transplantation Medicine and Dentistry 33%

Dalinghaus's research focuses on the intersection of molecular cardiac biology and clinical pediatrics, with particular emphasis on genetic factors in pediatric cardiomyopathies, microtubule-related cardiac disease mechanisms, and national outcomes in pediatric heart transplantation. Recent work examines FLII gene variants, microtubule signatures in cardiac disease, and genetic testing for risk stratification in dilated cardiomyopathy.

The publication record shows consistent output in high-impact journals with notable recent contributions including five significant articles from 2022-2023 covering pediatric heart failure mechanisms, microtubule biology in cardiac disease, genetic causes of cardiomyopathy, national heart transplantation outcomes, and genetic evaluation approaches for pediatric DCM.

Dalinghaus participates in collaborative research through the LENA Consortium and contributes to national Dutch research initiatives in pediatric cardiology, working with colleagues across multiple institutions on large-scale studies of pediatric heart conditions.

With 4 supervised students and ongoing research activity evidenced by 2023 publications, Dalinghaus maintains an active research program focused on improving understanding and treatment of complex pediatric cardiac conditions through both basic science and clinical research approaches.